首页> 外文期刊>Journal of pain & palliative care pharmacotherapy >Naloxone Prescribing and Education in Outpatient Pain Management and Palliative Care
【24h】

Naloxone Prescribing and Education in Outpatient Pain Management and Palliative Care

机译:门诊疼痛管理和姑息治疗中的纳洛酮处方与教育

获取原文
获取原文并翻译 | 示例
           

摘要

Over the past two decades, opioid use and overdose have increased substantially. Naloxone, an opioid overdose reversal agent, has been one of many risk mitigation strategies for preventing mortality due to overdose. Most literature describing naloxone utilization has been about populations of illicit drug users and patients in hospitals, primary care, and pharmacies. There is limited information regarding naloxone prescribing and training for opioid users in specialty pain management clinics. Furthermore, there are no known publications concerning patients receiving palliative care services and overdose prevention. Pain and palliative care patients are commonly at risk of opioid overdose. In an interdisciplinary outpatient pain and palliative care clinic, pharmacists implemented naloxone prescribing and education. Eleven patients at increased risk for overdose were prescribed naloxone and educated on overdose risk factors, recognition, and management. Seven patients reported picking up their naloxone prescription from the pharmacy, and none reported using it within two weeks of the initial education. This intervention was deemed successful within the clinic, but small sample size and the pharmacist role may not be replicable within other pain and palliative care settings. It encourages further research of overdose risk and prevention in pain management and palliative care.
机译:在过去20年中,阿片类药物的使用和过量大幅增加。纳洛酮是一种阿片类药物过量逆转剂,是预防因过量服用而死亡的众多风险缓解策略之一。大多数描述纳洛酮使用的文献都是关于医院、初级保健和药房中的非法药物使用者和患者的人群。关于专业疼痛管理诊所中阿片类药物使用者的纳洛酮处方和培训的信息有限。此外,还没有已知的关于接受姑息治疗服务和过量预防的患者的出版物。疼痛和姑息治疗患者通常有阿片类药物过量的风险。在一个跨学科的门诊疼痛和姑息治疗诊所,药剂师实施了纳洛酮处方和教育。11名药物过量风险增加的患者服用纳洛酮,并接受有关药物过量风险因素、识别和管理的教育。七名患者报告从药房拿到了纳洛酮处方,没有一名患者报告在最初接受教育的两周内使用了纳洛酮。这种干预在临床上被认为是成功的,但小样本和药剂师的角色可能无法在其他疼痛和姑息治疗环境中复制。它鼓励在疼痛管理和姑息治疗中进一步研究过量风险和预防。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号